Companies

Atricure Inc

NASDAQ: ATRC
$58.05
▼ $0.36 (−0.62%) today
Markets closed · 7:51pm ET

About AtriCure

AtriCure, Inc. specializes in creating and distributing innovative devices aimed at the surgical treatment of cardiac conditions. Their product lineup includes devices for cardiac tissue ablation, left atrial appendage exclusion, and nerve ablation for pain management. Notable offerings include the Isolator Synergy Clamps, multifunctional pens like the MAX Pen for cardiac arrhythmias, and the Coolrail device for extended linear ablations. They also offer the cryoICE Cryoablation System for linear ablations, EPi-Sense Systems for atrial fibrillation treatment, and the AtriClip System for soft-tissue closure. AtriCure markets its products globally, serving medical centers through direct sales and distributors. Headquartered in Mason, Ohio, the company was founded in 2000.

Latest Activity

House trade disclosureGilbert Ray Cisneros, Jr.
  • AMDAdvanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRCAtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more

ATRC Coverage